Philip P. Boudreau
Chief Financial Officer, Abbott Laboratories.
Companies
- Abbott LaboratoriesChief financial officer Mar 4, 2025 to now1
- Abbott LaboratoriesVice President Mar 9, 2020 to Feb 27, 20252
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Abbott Laboratories ABT72,984 shares3$7.6M at $104.71Sep 3, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 1, 2026Shares withheld for tax 388 shares at $110.36 of Abbott Laboratories3
- Apr 23, 2026Bought 2,200 shares at $91.50 of Abbott Laboratories4
- Apr 23, 2026I 8,909 shares at $92.04 of Abbott Laboratories4
- Feb 27, 2026Shares withheld for tax 7,441 shares at $116.26 of Abbott Laboratories5
- Feb 24, 2026Granted 27,997 shares of Abbott Laboratories6
- Sep 1, 2025Shares withheld for tax 387 shares at $132.66 of Abbott Laboratories7
- Aug 8, 2025Sold 5,550 shares at $134.55 of Abbott Laboratories8
- Feb 28, 2025Shares withheld for tax 4,908 shares at $135.87 of Abbott Laboratories9
- Feb 25, 2025Granted 22,495 shares of Abbott Laboratories10
- Sep 1, 2024Shares withheld for tax 387 shares at $113.27 of Abbott Laboratories11
- Feb 29, 2024Shares withheld for tax 1,738 shares at $120.05 of Abbott Laboratories12
- Feb 21, 2024Granted 23,024 shares of Abbott Laboratories13
- Sep 1, 2023Granted 2,620 shares of Abbott Laboratories14
- Jun 16, 2023Sold 8,000 shares at $106.00 of Abbott Laboratories15
- Feb 28, 2023Shares withheld for tax 1,477 shares at $99.77 of Abbott Laboratories16
- Feb 17, 2023Granted 4,855 shares of Abbott Laboratories17
- Feb 28, 2022Shares withheld for tax 1,192 shares at $122.41 of Abbott Laboratories18
- Feb 22, 2022Shares withheld for tax 966 shares at $116.79 of Abbott Laboratories19
- Feb 18, 2022Granted 5,351 shares of Abbott Laboratories19
- Oct 25, 2021Sold 8,000 shares at $126.49 of Abbott Laboratories20
- Feb 26, 2021Shares withheld for tax 704 shares at $121.58 of Abbott Laboratories21
- Feb 22, 2021Shares withheld for tax 937 shares at $123.04 of Abbott Laboratories22
- Feb 19, 2021Granted 4,997 shares of Abbott Laboratories22
- Feb 16, 2021Shares withheld for tax 943 shares at $128.23 of Abbott Laboratories23
- Mar 13, 2020Sold 10,600 shares at $82.00 of Abbott Laboratories24
Trade performance
| Date | Stock | Trade | Value | Return since | Vs S&P since | Vs S&P, 1 year |
|---|---|---|---|---|---|---|
| Apr 23, 2026 | ABT | Buy | $201.3K | +13.4% | +4.5% | |
| Aug 8, 2025 | ABT | Sale | $746.8K | −21.9% | +43.0% | +40.4% |
| Jun 16, 2023 | ABT | Sale | $848.0K | −1.2% | +76.9% | +27.1% |
| Oct 25, 2021 | ABT | Sale | $1.0M | −17.1% | +86.6% | +7.1% |
| Mar 13, 2020 | ABT | Sale | $869.2K | +28.5% | +158.1% | +2.5% |
Returns are price-only (no dividends), measured from the trade date.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARAbbott Laboratories, Vice President
- 3
- 4SEC EDGARForm 4 filed Apr 27, 2026
- 5SEC EDGARForm 4 filed Mar 3, 2026
- 6SEC EDGARForm 4 filed Feb 26, 2026
- 7SEC EDGARForm 4 filed Sep 3, 2025
- 8SEC EDGARForm 4 filed Aug 11, 2025
- 9SEC EDGARForm 4 filed Mar 4, 2025
- 10SEC EDGARForm 4 filed Feb 27, 2025
- 11SEC EDGARForm 4 filed Sep 4, 2024
- 12SEC EDGARForm 4 filed Mar 4, 2024
- 13SEC EDGARForm 4 filed Feb 23, 2024
- 14SEC EDGARForm 4 filed Sep 6, 2023
- 15SEC EDGARForm 4 filed Jun 20, 2023
- 16SEC EDGARForm 4 filed Mar 2, 2023
- 17SEC EDGARForm 4 filed Feb 22, 2023
- 18SEC EDGARForm 4 filed Mar 2, 2022
- 19SEC EDGARForm 4 filed Feb 23, 2022
- 20SEC EDGARForm 4 filed Oct 27, 2021
- 21SEC EDGARForm 4 filed Mar 2, 2021
- 22SEC EDGARForm 4 filed Feb 23, 2021
- 23SEC EDGARForm 4 filed Feb 18, 2021
- 24SEC EDGARForm 4 filed Mar 16, 2020